Genix Pharmaceuticals Corp

GENX.CA

$0.03

Closing

0.00

1D

▲75.00%

YTD

GENX

BBG001S5XRP2

Market cap

$1.53M

52 week high

$0.07

52 week low

$0.01

Volume

64,000

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$1.53M

Analysts' Rating

-

Price Target (Mean)

0

Total Analysts

0

P/E

Operating Margin

-1666.32%

Beta

-0.47

Revenue Growth

-63.96%

52 week high

$0.07

52 week low

$0.01

Div. Yield

%

EPS Growth

0

Company Profile

Genix Pharmaceuticals Corporation is a life-sciences company. The Company is a formulator, manufacturer, licensor and marketer of life sciences related products with a focus on nutraceuticals and pharmaceuticals. The Company is focused on the research, development, manufacturing, licensing and selling of novel and healthcare products. These products include evidence-based, proprietary over the counter (OTC) nutraceuticals, and other single molecule generic drugs. The Company has been marketing and selling other nutraceuticals and some pharmaceutical products, such as bee propolis capsules, calcium liquid soft gels, seal oil soft gels, marine lipid soft gels, Lecithin soft gels, fish oil soft gels, EPO soft gels and spirulina powder. Its products include Ketorolac 0.5% Eye Drops, Timolol 0.5% Eye Drops, Diclofenac 0.1% Eye Drops, Moxifloxacin Hydrochloride 0.5% Eye Drops, Prednisolone Acetate 1% Eye Drops, Olopatadine 0.1% Eye Drops, and Artificial Tearssingle-molecule.